Legionella species
Legionella pneumophila; Legionella longbeachae
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
Gram-negative rods from water systems (L. pneumophila) or soil and potting mix (L. longbeachae), acquired by inhaling contaminated aerosols or dust.
Infections
Legionnaires' disease (pneumonia) and Pontiac fever (a milder flu-like illness).
Signs and symptoms
High fever, cough, shortness of breath, muscle aches, headache, diarrhea; low sodium is common.
Antibiotic and antimicrobial resistance
Clinically relevant resistance is uncommon.
Treatment considerations
Azithromycin or a respiratory fluoroquinolone (levofloxacin). Beta-lactams are ineffective.
Infection control and public health
Nationally notifiable; a healthcare-associated case should prompt investigation of the facility water system.

Sources
- CDC. Legionnaires' disease.
- ATS / IDSA. Community-Acquired Pneumonia in Adults guideline.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.